A Phase IIb Study of BPI-7711 Capsule in Non-small Cell Lung Cancer Patients With T790M Mutation Positive
NCT03812809
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
226
Enrollment
INDUSTRY
Sponsor class
Conditions
NSCLC
Interventions
DRUG:
BPI-7711
Sponsor
Beta Pharma Shanghai